Articure

AtriCure is a publicly traded medical device company focused on surgical and hybrid therapies for atrial fibrillation, left atrial appendage management, and post-operative pain management. Its core commercial portfolio includes the Isolator Synergy ablation system, the AtriClip left atrial appendage exclusion products, the EPi-Sense family used in Hybrid AF Therapy, and cryoICE/cryoSPHERE nerve block technologies. The company sells globally and supports adoption through physician training, clinical science, and education. AtriCure is not a drug-development biotech; it is a commercial-stage cardiovascular and pain-management medtech company with integrated R&D and manufacturing operations centered in Ohio.